Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 340articles · 30d
- 2+ hour agolatest article
- Aug 17, 2026earliest in window
- 91%with images
- 291avg words
- Economy, Business & Finance 195
- Health & Wellness 159
- Medical 158
- Business & Industrial 142
- Finance & Business 132
- Health 75
- Science & Technology 53
- Science & Nature 34
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs
3+ day, 11+ hour ago (140+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
BioLife Secures U.S. Patent for First-of-its-kind Effervescent Oral Peptide Delivery Technology
3+ day, 11+ hour ago (399+ words) PARIS--(BUSINESS WIRE)--BioLife today announced that the United States Patent and Trademark Office has granted U.S. Patent 12,667,605 B2 for its novel effervescent oral peptide delivery technology, designed to support current and future peptide therapeutics for obesity, diabetes and metabolic disease. The…...
Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drug
3+ day, 16+ hour ago (274+ words) Biohaven stock fell more than 13% in premarket trading Thursday as the FDA slapped a partial clinical hold on its Kv7 potassium channel agonist in focal epilepsy. This latest development comes days after SK Biopharmaceuticals snagged a worldwide license to the Kv7 platform,…...
Drugmakers cherry pick launch regions as MFN creates 'policy environment like an earthquake"
3+ day, 13+ hour ago (406+ words) No more is launching a drug a “straight math exercise,” as Most Favored Nation drug pricing pressures drugmakers to reconsider launch sequences to ensure the best price can be achieved in the main global market: the United States. That’s according…...
Encoded raises $275M series F for Dravet syndrome gene therapy
3+ day, 13+ hour ago (423+ words) Encoded Therapeutics has closed a $275 million series F round to help advance its investigational Dravet syndrome therapy into pivotal development. Much of the proceeds will go toward Encoded’s lead asset ETX101, according to a Wednesday release. The therapy is being tested…...
For PDUFA VIII, the most valuable incentive may be time
4+ day, 1+ hour ago (506+ words) For a small biotech, the more practical incentive is time. Speed matters—whether a drug succeeds or fails. Finding out earlier that the biology is wrong stops further investment, limits unnecessary exposure of patients and allows scientists and resources to…...
Atman Health Wins ARPA-H Award to Build Agentic AI for Cardiovascular Care, Starting with Heart Failure
4+ day, 32+ min ago (122+ words) Access to cardiologists compounds the problem. A 2024 analysis in the Journal of the American College of Cardiology found that 1,454 of the 3,143 counties in the United States have no practicing cardiologist. Optimizing medications for millions of patients requires repeated clinical contact…...
Guided Therapeutics Reaches Collaborative Agreement with T??rkiye???s Ministry of Health to Become Primary Screening Test for Cervical Cancer
4+ day, 15+ hour ago (275+ words) Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer BioSpace Guided Therapeutics Reaches Collaborative Agreement with Türkiye’s Ministry of Health to Become Primary Screening Test for Cervical Cancer PEACHTREE CORNERS, Ga....
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism
4+ day, 12+ hour ago (169+ words) Initiation of Phase 3 registrational study on track by year-end; topline results expected in late 2028; U.S. FDA approval and launch anticipated in 2030 The Company expects XP-8121 peak net revenue potential of $1 to $3 billion Capstone — Pediatric Study Touchstone — Special Population Study Clinical Perspective…...
Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured
4+ day, 12+ hour ago (548+ words) Persephone's Synbiotic Range for Infants and Toddliers Thousands of U.S. children have taken Bloom and Thrive since their commercial launch one year ago. Bloom and Thrive were designed to put back key beneficial bacteria found to be missing from the developing…...